Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/05/008480
CTRI/2017/05/008480
Completed
Phase 2

An open-label randomized clinical study for the comparative effectiveness of constitutional homoeopathic medicine with Dysentery Compound in cases of Irritable Bowel Syndrome

ational Institute of Homoeopathy Ministry of AYUSH Govt of India0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Irritable Bowel Syndrome

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Irritable Bowel Syndrome
Sponsor
ational Institute of Homoeopathy Ministry of AYUSH Govt of India
Enrollment
60
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 7, 2017
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Homoeopathy Ministry of AYUSH Govt of India

Eligibility Criteria

Inclusion Criteria

  • •1\. Age 18 to 65 years
  • •2\. Both sexes
  • •3\. Symptomatic IBS for at least 2 days/week over 3 months
  • •4\. IBS diagnosed and sub\-typed as per Rome III criteria

Exclusion Criteria

  • •1\. Patients who are too sick for consultation
  • •2\. Unable to read patient information sheets and/or not giving consent to join the study
  • •3\. Diagnosed cases of unstable mental or psychiatric illness or other systemic disease affecting quality of life
  • •4\. Major gastro\-intestinal surgery in last 6 months
  • •5\. Currently receiving standard therapy for IBS and/or undergoing homoeopathic treatment for chronic condition(s)
  • •6\. Pregnant and lactating women
  • •7\. Self\-reported immune\-compromised state
  • •8\. Substance abuse and/or dependence

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
A clinical study on combined effect of sahacharadi syrup and ayurvedic enema therapy in sciatica.Health Condition 1: M543- Sciatica
CTRI/2018/08/015289Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Not yet recruiting
Phase 2
A combined study 0f combined effectiveness, Lodhradi Kashaya And Navaka Guggulu in patients with Madumeha (Type 2 Diabetes Mellitus)Health Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2023/08/056755Sri Dharmasthala Manjunatheswara College of Ayurveda and
Completed
Not Applicable
A randomized open-label prospective trial for comparing combination therapy Peg-Interferon alfa-2a (PEGASYS®) and Adefovir dipivoxil (Hepsera®) and combination therapy Peg-Interferon alfa-2a (PEGASYS®) and Tenofovir disoproxil fumarate (Viread®) versus no treatment in HBeAg negative chronic hepatitis B patients with low viral load*chronic hepatitis Bviral hepatitis1001965410047438
NL-OMON32978Academisch Medisch Centrum150
Completed
Not Applicable
An open label, randomized control study for the comparison of effectiveness between Alfa-Glucosidase inhibitor and Dipeptidyl peptidase-4 (DPP-4) inhibitor in people with type 2 diabetes treated diet therapy and/or single oral hypoglycemic agentType 2 diabetes
JPRN-UMIN000003503Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science260
Completed
Not Applicable
An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetesType 2 diabetes
JPRN-UMIN000008369Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences38